Rating History for Kymera Therapeutics (KYMR) by Goldman Sachs
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 9/24/2026 | Andrea Newkirk | New Coverage | Early-Stage Biotech (N/A) |
N/A (N/A) |
115.47 (108.07) |
-6.41% | Details |
 |
|||||||
